ethyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate, 97%, 2.5g

4-Methoxy-2-(piperidin-4-yloxy)pyrimidine hydrochloride, 1g

2-CHLORO-4-FORMYLPHENYL TRIFLUOROMETHANESULFONATE, 95.0%, 500mg

3-Thiophenecarboxylic acid, 98.0%, 500g

Methyl 6-((tert-butoxycarbonyl)amino)spiro[3.3]heptane-2-carboxylate, 95.0%, 100mg

Dimethyl({[(3S)-pyrrolidin-3-yl]methyl})amine dihydrochloride, 97%, 500mg

SODIUM 2-METHYL-4,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLATE, 95%, 100mg

(S)-tert-butyl 4-(1-hydroxyethyl)piperidine-1-carboxylate, 98%, 500mg

2-Fluoro-5-methylbenzylamine, 95%, 250mg

4-(3-chlorophenyl)-1H-pyrazol-5-amine, 95.0%, 5g

Acetohydroxamic acid, 97.0%, 1kg

Trial kit Spectra/Por® 1-3 Spectra/Por® 3 - MWCO 3500, 54 mm, 1 Piece(s)

Diethylene Glycol Divinyl Ether (stabilized with KOH)>98.0%(GC)100mL